Editas Medicine Inc (NASDAQ:EDIT)

Delayed Data
As of 4:00pm ET
 +2.85 / +10.14%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 46.00, with a high estimate of 81.00 and a low estimate of 18.00. The median estimate represents a +48.58% increase from the last price of 30.96.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Editas Medicine Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -27.13%
Growthannually -52.34%


Growthquarterly -30.89%
Growthannually -80.62%
Key to the earnings and sales forecast charts.